Determining the diagnostic value of PSMA-PET/CT imaging in patients with persistent high prostate specific antigen levels and negative prostate biopsies.

Autor: Bodar, YJL^1,2 (AUTHOR) y.j.bodar@amsterdamumc.nl, Koene, BPF¹ (AUTHOR), Meijer, D^1,2 (AUTHOR), van Leeuwen, PJ³ (AUTHOR), Nadorp, S⁴ (AUTHOR), Donswijk, ML⁵ (AUTHOR), Hendrikse, NH^2,6 (AUTHOR), Oprea-Lager, DE² (AUTHOR), Vis, AN¹ (AUTHOR), van Leeuwen, P J³ (AUTHOR), Donswijk, M L⁵ (AUTHOR), Hendrikse, N H⁷ (AUTHOR), Oprea-Lager, D E² (AUTHOR), Vis, A N¹ (AUTHOR)

Publikováno v: Urologic Oncology. Feb2022, Vol. 40 Issue 2, p58.e1-58.e7. 1p.

Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.

Autor: Meijer D; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Eppinga WSC; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Vanneste BGL; Department of Radiation Oncology, Maastricht University Medical Center, Maastricht, The Netherlands.; Departments of Radiation Oncology and Human Structure and Repair, Ghent University Hospital, Ghent, Belgium., Meijnen P; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., Daniels LA; Department of Radiation Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands., van den Bergh RCN; Department of Urology, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands., Lont AP; Department of Urology, Meander Medical Center, Amersfoort, The Netherlands., Bodar YJL; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Ettema RH; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., de Bie KCC; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Oudshoorn FHK; Department of Urology, Spaarne Gasthuis, Haarlem, The Netherlands., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., van der Poel HG; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands., Donswijk ML; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Heymans MW; Department of Epidemiology and Data Science, Amsterdam University Medical Center, VU University, Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands., Schaake EE; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Center, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.; Department of Urology, The Netherlands Cancer Institute, Prostate Cancer Network Netherlands, Amsterdam, The Netherlands.

Publikováno v: European urology open science [Eur Urol Open Sci] 2024 Feb 06; Vol. 61, pp. 37-43. Date of Electronic Publication: 2024 Feb 06 (Print Publication: 2024).

Higher Preoperative Maximum Standardised Uptake Values (SUV max ) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [ ⁶⁸ Ga]Ga-PSMA-11 and [ ¹⁸ F]DCFPyL Positron Emission Tomography/Computed Tomography.

Autor: de Bie KCC; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands., Veerman H; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.; Department of Urology, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Bodar YJL; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands., Meijer D; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands., van Leeuwen PJ; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.; Department of Urology, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van der Poel HG; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands.; Department of Urology, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Donswijk ML; Department of Radiology and Nuclear Medicine, Antoni van Leeuwenhoek Hospital-The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Vis AN; Department of Urology, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.; Prostate Cancer Network The Netherlands, 1066 CX Amsterdam, The Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, VU University, Amsterdam University Medical Centers, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

Publikováno v: Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Jul 11; Vol. 13 (14). Date of Electronic Publication: 2023 Jul 11.

The oncological characteristics of non-prostate-specific membrane antigen (PSMA)-expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography.

Autor: Veerman H; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands., Donswijk M; Department of Nuclear Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Bekers E; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Bodar YJL; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands., van Moorselaar RJA; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van Leeuwen PJ; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands., van der Poel HG; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Urology, Amsterdam University Medical Centres, Location VU Medical Centre, Amsterdam, the Netherlands.; Prostate Cancer Network Netherlands, Amsterdam, the Netherlands.

Publikováno v: BJU international [BJU Int] 2022 Dec; Vol. 130 (6), pp. 750-753. Date of Electronic Publication: 2022 Sep 30.

Prospective analysis of clinically significant prostate cancer detection with [ ¹⁸ F]DCFPyL PET/MRI compared to multiparametric MRI: a comparison with the histopathology in the radical prostatectomy specimen, the ProStaPET study.

Autor: Bodar YJL; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands. y.j.bodar@amsterdamumc.nl.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands. y.j.bodar@amsterdamumc.nl.; Prostate Cancer Network, Amsterdam, the Netherlands. y.j.bodar@amsterdamumc.nl., Zwezerijnen BGJC; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., van der Voorn PJ; Department of Pathology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Jansen BHE; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Prostate Cancer Network, Amsterdam, the Netherlands., Smit RS; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Kol SQ; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Meijer D; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Prostate Cancer Network, Amsterdam, the Netherlands., de Bie K; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Yaqub M; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Windhorst BAD; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Hendrikse HNH; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands., Vis AN; Department of Urology, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.; Prostate Cancer Network, Amsterdam, the Netherlands., Oprea-Lager DE; Department of Radiology & Nuclear Medicine, Amsterdam University Medical Centres (VU University Medical Center), Amsterdam, the Netherlands.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2022 Apr; Vol. 49 (5), pp. 1731-1742. Date of Electronic Publication: 2021 Nov 02.